These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 832235)

  • 1. Combination chemotherapy using cyclophosphamide, vincristine, methotrexate, 5-fluorouracil, and prednisone in solid tumors.
    Bearden JD; Coltman CA; Moon TE; Costanzi JJ; Saiki JH; Balcerzak SP; Rivkin SE; Morrison FS; Lane M; Spigel SC
    Cancer; 1977 Jan; 39(1):21-6. PubMed ID: 832235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy of metastasizing breast cancers. Indications and results].
    Gallmeier WM; Bruntsch U; Schmidt CG
    Dtsch Med Wochenschr; 1975 Jan; 100(2):35-41. PubMed ID: 1112210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of advanced breast cancer with a combination of vincristine, fluorouracil, methotrexate, cyclophosphamide and prednisone].
    Rosso R; Brema F; Santi L
    Tumori; 1973; 59(2):163-5. PubMed ID: 4720643
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB; White DR; Cooper MR; Richards F; Spurr CL
    Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S; Goldstein M
    Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
    [No Abstract]   [Full Text] [Related]  

  • 9. Five-drug combination chemotherapy for disseminated adenocarcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Dec; 56(6):761-7. PubMed ID: 4660632
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further clinical studies of combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-flourouracil in solid tumors.
    Coltman CA; Costanzi JJ; Dudley GM; Haut A; Lane M; Gehan EA
    Am J Med Sci; 1971 Feb; 261(2):73-8. PubMed ID: 5550137
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH; Blom J; Tormey DC
    Oncology; 1974; 29(2):139-46. PubMed ID: 4525917
    [No Abstract]   [Full Text] [Related]  

  • 15. An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine.
    Ahmann DL; Bisel HF; Hahn RG; Eagan RT; Edmonson JH; Steinfeld JL; Tormey DC; Taylor WF
    Cancer; 1975 Dec; 36(6):1925-35. PubMed ID: 1203855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 17. Bleomycin combination chemotherapy in the management of testicular neoplasia.
    Samuels ML; Holoye PY; Johnson DE
    Cancer; 1975 Aug; 36(2):318-26. PubMed ID: 50869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient chemotherapy of advanced breast cancer in a community setting: a five-drug regimen.
    West JH
    South Med J; 1976 Jun; 69(6):741-6. PubMed ID: 935904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.
    Hanham IW; Newton KA; Westbury G
    Br J Cancer; 1971 Sep; 25(3):462-78. PubMed ID: 5144521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quadruple chemotherapy in the treatment of advanced or recurrent gastrointestinal carcinoma.
    Cheng FC; Lee CM; Ong GB
    Clin Oncol; 1977 Jun; 3(2):191-5. PubMed ID: 872473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.